dimethylnitrosamine has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, Y; Inaguma, S; Kato, H; Komura, M; Matsuo, Y; Nagayasu, Y; Naiki-Ito, A; Takahashi, S; Takiguchi, S; Tomita, M; Tsuda, H; Xiaochen, K | 1 |
| Aoyama, Y; Inaguma, S; Kato, H; Nagayasu, Y; Naiki, T; Naiki-Ito, A; Suzuki, S; Takahashi, S; Yeewa, R | 1 |
2 other study(ies) available for dimethylnitrosamine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
Topics: Animals; Anticarcinogenic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Connexins; Cytokines; Dimethylnitrosamine; Fibrosis; Gap Junction beta-1 Protein; Lactoferrin; Liver; Liver Cirrhosis; Liver Neoplasms; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2021 |
A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats.
Topics: Animals; Cell Transformation, Neoplastic; Connexins; Cytokines; Diet, High-Fat; Dimethylnitrosamine; Disease Progression; Gap Junction beta-1 Protein; Inflammation Mediators; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats, Transgenic; Signal Transduction | 2020 |